The Third Affiliated Hospital Of Guangzhou Medical University
Clinical trials sponsored by The Third Affiliated Hospital Of Guangzhou Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Pregnant women with hepatitis b: which drug is safer? Results expected Mar 2027 (estimated)
- Mitochondrial DNA mutation may be a hidden cause of male infertility Results expected Apr 2027 (estimated)
-
Pregnant women with hepatitis b: which drug is safer?
Disease control By invitation onlyThis study looks at two antiviral drugs, TAF and TDF, in pregnant women with chronic hepatitis B. It aims to see which one better controls the virus and keeps the mother's liver healthy without harming the baby. About 816 women in early or middle pregnancy will take one of the dr…
Phase 4 • Sponsor: The Third Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Pregnancy hepatitis b drug showdown: which is safer for mom and baby?
Disease control By invitation onlyThis study tests two antiviral medications, TAF and TDF, in 200 pregnant women with chronic hepatitis B. The goal is to see which drug better prevents passing the virus to the baby and causes fewer birth defects or side effects. Participants take the drug daily during pregnancy a…
Phase 4 • Sponsor: The Third Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC